Dechra Pharmaceuticals PLC
21 December 2007
1. Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached:
DECHRA PHARMACEUTICALS PLC
2. Reason for notification
(please place an X inside the appropriate bracket/s):
An acquisition or disposal of voting rights: (YES)
An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached: ( )
An event changing the breakdown of voting rights: ( )
Other (please specify) : ( )
3. Full name of person(s) subject to notification obligation:
SCHRODERS PLC
4. Full name of shareholder(s) (if different from 3) :
5. Date of transaction (and date on which the threshold is crossed or reached
if different):
20 DECEMBER 2007
6. Date on which issuer notified:
21 DECEMBER 2007
7. Threshold(s) that is/are crossed or reached:
FROM 13% TO 12%
8. Notified Details:
A: Voting rights attached to shares
Class/type of shares Situation previous to
if possible use the Triggering transaction
ISIN CODE
Number of shares Number of voting Rights
ORDINARY 6,932,568 6,932,568
SHARES
GB0009633180
Resulting situation after the triggering transaction
Class/type of shares Number of shares Number of voting rights % of voting rights
if possible use
ISIN CODE Direct Indirect Direct Indirect
ORDINARY N/A N/A 6,809,023 N/A 12.89%
SHARES
GB0009633180
B: Financial Instruments
Resulting situation after the triggering transaction
Type of Expiration date Exercise/conversion No. of voting % of voting
financial period/date rights that may rights
instrument be acquired (if
the instrument
exercised/
converted)
Total (A+B)
Number of voting rights % of voting rights
6,809,023 12.89%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
SCHRODER INVESTMENT MANAGEMENT LIMITED 5,998,904 11.36%
SCHRODER INVESTMENT MANAGEMENT NORTH AMERICA LIMITED 810,119 1.53%
Proxy Voting:
10. Name of proxy holder:
N/A
11. Number of voting rights proxy holder will cease to hold:
N/A
12. Date on which proxy holder will cease to hold voting rights:
N/A
13. Additional information:
14. Contact name:
VICKY WARD
15. Contact telephone number:
020 7658 3750
This information is provided by RNS
The company news service from the London Stock Exchange
HOLGGMZZNMKGNZM
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.